Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.

MLA

Leyva, Francisco, et al. “Long-Term Clinical Outcomes of Cardiac Resynchronization Therapy with or without Defibrillation: Impact of the Aetiology of Cardiomyopathy.” Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol. 20, no. 11, Nov. 2018, pp. 1804–12. EBSCOhost, https://doi.org/10.1093/europace/eux357.

APA

Leyva, F., Zegard, A., Umar, F., Taylor, R. J., Acquaye, E., Gubran, C., Chalil, S., Patel, K., Panting, J., Marshall, H., & Qiu, T. (2018). Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 20(11), 1804–1812. https://doi.org/10.1093/europace/eux357

Chicago

Leyva, Francisco, Abbasin Zegard, Fraz Umar, Robin James Taylor, Edmund Acquaye, Christopher Gubran, Shajil Chalil, et al. 2018. “Long-Term Clinical Outcomes of Cardiac Resynchronization Therapy with or without Defibrillation: Impact of the Aetiology of Cardiomyopathy.” Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 20 (11): 1804–12. doi:10.1093/europace/eux357.